Tue, Sep 16, 2014, 12:42 PM EDT - U.S. Markets close in 3 hrs 18 mins


% | $
Quotes you view appear here for quick access.

Heska Corporation Message Board

  • tommccauley31 tommccauley31 Mar 21, 2013 10:14 AM Flag

    1st Quarter Qwilled:

    With one week remaining to post 1st quarter revenue
    shareholders cannot take solace in the companies
    reluctance to give guidance.
    Heska has morphed itself into a re-seller of veterinary
    products that have become commodities. Thus the
    low (grocery store) operating margins.
    Heska often repeats a caution in conference calls.
    "Because the cyclical nature of recurring orders is
    difficult to predict, we caution results may not meet
    projections". In other words!!!! Heska relies on the
    annual orders from Merck Animal Health, and Agrilabs
    to boost sales. The first 2 quarters of Heska's year
    have traditionally been their best because heartworm
    screening and preventives comprise a bigger share
    of business. Heska blamed weather conditions for
    poor 2012 sales of heartworm products?
    Heska had so much excess inventory of SoloStep
    that the company discounted price in late 2012 to
    encourage buyers. Heska also cannablized this
    years sales of SoloStep by stocking the product
    for distribution at MWIV in the 4th quarter of last year.
    I expect comps of 1st quarter Heska revenues to be
    worse than 2012. I do not expect Cuattro to have much
    of an impact until latter in the year.
    If Bob Grieve doesn't want to give guidance?
    Why should shareholders expect good news?

12.67-0.11(-0.86%)12:41 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.